US Tardive Dyskinesia Market to See Fast Growth to 2025, Expects Daedal Research in Its Report Available at MarketPublishers.com19 Dec 2016 • by Natalie Aster
LONDON – Tardive dyskinesia (TD) is a side effect of antipsychotic drug products that are utilised for the treatment of schizophrenia and other mental health illnesses.
TD has many various treatments, comprising vitamin E, levodopa, benzodiazepines, reserpine, tetrabenazine, botullinum toxin, dopamine-depleting agents, and calcium antagonists. Valbenazine and SD-809 are currently are in the pipeline.
The tardive dyskinesia market in the USA is poised to grow at a fast rate through to 2025. The major drivers of growth are an upsurge in the number of patients with schizophrenia, a rising number of manic depression patients, and more. However, the market is faced with specific challenges, like wider use of atypical antipsychotic drugs, under-diagnosed marketplace, side effects of drugs, among others.
Neurocrine Biosciences, Valeant Pharmaceuticals and Teva Pharmaceutical Industries are some of the dominant firms operating in the country’s tardive dyskinesia marketplace.
In-demand research report “US Tardive Dyskinesia Market: Size, Trends & Forecasts (2016-2025)” developed by Daedal Research provides an extensive analysis of the tardive dyskinesia market on a national level. The research report presents a granular analysis of the market size and tempo of growth, market shares, rate of penetration, and economic effect of the industry. It also provides insights into the major drugs, existing and in development, based on penetration and revenue, etc.
Further, the report evaluates the key opportunities in the marketplace as well as limelights the factors responsible for the current and prospective growth of the industry. The study offers detailed forecasts of the overall US tardive dyskinesia market to 2025, considering the past growth trajectory, the growth drivers in tandem with the current and prespective trends. Furthermore, the report offers exhaustive profiles of the top companies, covering business overview, financials and pertinent business strategies.
More in-demand reports drawn up by Daedal Research can be found at its page.